UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 154

Sortiert nach

Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response

International journal of radiation oncology, biology, physics, 2021-05, Vol.110 (1), p.237-248

2021

Volltextzugriff (PDF)

Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2021-05, Vol.110 (1), p.227-236

2021

Volltextzugriff (PDF)

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

JAMA network open, 2019-02, Vol.2 (2), p.e188006

2019

Volltextzugriff (PDF)

Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial

International journal of radiation oncology, biology, physics, 2018-12, Vol.102 (5), p.1430-1437

2018

Volltextzugriff (PDF)

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

Frontiers in oncology, 2022-07, Vol.12, p.935310-935310

2022

Volltextzugriff (PDF)

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer

Frontiers in oncology, 2020-12, Vol.10, p.627686-627686

2020

Volltextzugriff (PDF)

Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.149-154

2019

Volltextzugriff (PDF)

Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes

European urology oncology, 2018-12, Vol.1 (6), p.540-547

2018

Volltextzugriff (PDF)

A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy

American journal of clinical oncology, 2018-05, Vol.41 (5), p.502-507

2018

Volltextzugriff (PDF)

Balancing on a Knife's Edge: Evidence-Based Medicine and the Marketing of Health Technology. In Regard to Bentzen et al. ( Int J Radiat Oncol Biol Phys 2008;72:12–14)

International journal of radiation oncology, biology, physics, 2009-02, Vol.73 (2), p.637-638

Fuller, Donald B., M.D

2009

Volltextzugriff (PDF)

Regarding relative toxicities of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer

Journal of clinical oncology, 2014-10, Vol.32 (30), p.3455-3456

Fuller, Donald B

2014

Volltextzugriff (PDF)

Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series

Advances in radiation oncology, 2021-11, Vol.6 (6), p.100759-100759, Article 100759

2021

Volltextzugriff (PDF)

Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients

International journal of radiation oncology, biology, physics, 2021-07, Vol.110 (3), p.731-737

2021

Volltextzugriff (PDF)

Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations

International journal of radiation oncology, biology, physics, 2008-04, Vol.70 (5), p.1588

2008

Volltextzugriff (PDF)

Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus

Cancer treatment reviews, 2021-07, Vol.98, p.102206, Article 102206

2021

Volltextzugriff (PDF)

Virtual HDRSM CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations

International journal of radiation oncology, biology, physics, 2008-04, Vol.70 (5), p.1588-1597

2008

Volltextzugriff (PDF)

Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control

Radiotherapy and oncology, 2021-01, Vol.154, p.207-213

2021

Volltextzugriff (PDF)

High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment

Practical Radiation Oncology, 2015-11, Vol.5 (6), p.e615-e623

2015

Volltextzugriff (PDF)

Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors

Brachytherapy, 2004, Vol.3 (1), p.10-19

2004

Volltextzugriff (PDF)

Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy

American journal of roentgenology (1976), 2011-10, Vol.197 (4), p.907

2011

Volltextzugriff (PDF)

Testicular Dose From Prostate CyberKnife: A Cautionary Note in Regard to King et al. ( Int J Radiat Oncol Biol Phys 2008;73:636–637)

International journal of radiation oncology, biology, physics, 2009-02, Vol.73 (2), p.637-637

Fuller, Donald B., M.D

2009

Volltextzugriff (PDF)

CT–ultrasound fusion prostate brachytherapy: A dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases

Brachytherapy, 2005, Vol.4 (3), p.207-216

2005

Volltextzugriff (PDF)

Computed tomography–ultrasound fusion brachytherapy: Description and evolution of the technique

Brachytherapy, 2007-10, Vol.6 (4), p.272-279

2007

Volltextzugriff (PDF)

Robotic Radiosurgery Treating Prostate Cancer and Related Genitourinary Applications

1. Aufl., 2011

Volltextzugriff (PDF)

Early surrogate measures for ablative therapies for intermediate-risk prostate cancer patients

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.241-241

2021

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(73)
Humans
(59)
Male
(39)
Female
(29)
Oncology
(28)
Biological And Medical Sciences
(27)
Medical Sciences
(24)
Adult
(19)
Prostate Cancer
(19)
Middle Aged
(18)
Radiology, Nuclear Medicine & Medical Imaging
(17)
Aged
(16)
Treatment Outcome
(12)
Prostatic Neoplasms - Radiotherapy
(11)
Animals
(9)
Prostatic Neoplasms - Surgery
(9)
Radiology
(9)
Stereotactic Body Radiotherapy
(9)
Adolescent
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response

Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

Patient and Dosimetric Predictors of Genitourinary and Bowel Quality of Life After Prostate SBRT: Secondary Analysis of a Multi-institutional Trial

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer

Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials

Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes

A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy

Balancing on a Knife's Edge: Evidence-Based Medicine and the Marketing of Health Technology. In Regard to Bentzen et al. ( Int J Radiat Oncol Biol Phys 2008;72:12–14)

Regarding relative toxicities of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer

Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series

Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients

Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations

Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus

Virtual HDRSM CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations

Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control

High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment

Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors

Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy

Testicular Dose From Prostate CyberKnife: A Cautionary Note in Regard to King et al. ( Int J Radiat Oncol Biol Phys 2008;73:636–637)

CT–ultrasound fusion prostate brachytherapy: A dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases

Computed tomography–ultrasound fusion brachytherapy: Description and evolution of the technique

Robotic Radiosurgery Treating Prostate Cancer and Related Genitourinary Applications

Early surrogate measures for ablative therapies for intermediate-risk prostate cancer patients

Suchergebnisse filtern